Tweets by FSCDR's 17th Annual SCD Research and Educational Symposium & 46th Nat'l SCD Scientific Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Stream

NOTE: All events are in Eastern Daylight Time Zone. Please visit your Symposium Profile to verify your time zone. We recommend displaying all times in the event time zone.

Curative Options in Sickle Cell Disease Plenary Session

Q&A Panel

Saturday, June 17, 2023

4:30 PM – 4:45 PM East Coast USA Time

Location: Grand Salons A-E

Panelist(s)

Adetola Kassim, M.B.B.S, MS, FACP

Director, Stem Cell Transplant and Cellular Therapy Program Co-Director, Sickle ell Center of Excellence
Vanderbilt University Medical Center
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Jen Leiding, MD (she/her/hers)

Medical Director
bluebird bio, Inc.
Somerville, Massachusetts, United States
Aric Parnes, MD (he/him/his)

Associate Medical Director
Vertex Phamaceuticals
Boston, Massachusetts, United States
OA

Olubunmi Afonja, MD, MBA (she/her/hers)

Senior Director Clinical Development
Editas Medicine
Upper Saddle River, New Jersey, United States

Disclosure(s):

Adetola Kassim, M.B.B.S, MS, FACP: No financial relationships to disclose

Jen Leiding, MD: No financial relationships to disclose

Aric Parnes, MD: No relevant disclosure to display

Olubunmi Afonja, MD, MBA: No relevant disclosure to display

Learning Objectives:

Understand recent updates on the use of haploidentical hematopoietic stem cell transplant as a curative modality for sickle cell disease
Participants will understand the pros and cons of the use of haploidentical stem cell transplant for sickle cell disease
Discuss the challenges and pitfalls of haploidentical hematopoietic stem cell transplant as a curative modality for sickle cell disease